Cas:126518-75-0 [(2S,3S)-3-hydroxy-3-methoxycarbonyl-4-methylpentan-2-yl] benzoate manufacturer & supplier

Chemical Name:[(2S,3S)-3-hydroxy-3-methoxycarbonyl-4-methylpentan-2-yl] benzoate

CAS.NO:126518-75-0

Synonyms:Methyl 3-benzoyloxy-2-hydroxy-2-isopropylbutyrate;Asarumin A

Molecular Formula:C₁₅H₂₀O₅

Molecular Weight:280.31600

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:399.4ºC at 760mmHg

Density:1.145g/cm3

Index of Refraction:1.513

PSA:72.83000

Exact Mass:280.13100

LogP:1.79200

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Methyl 3-benzoyloxy-2-hydroxy-2-isopropylbutyrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Asarumin A physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Asarumin A Use and application,Asarumin A technical grade,usp/ep/jp grade.

Related News: What’s more, also at the EHA meeting, BeiGene’s Brukinsa showed it could outperform Imbruvica at triggering tumor responses while causing fewer cases of atrial fibrillation, a potentially dangerous heart side effect, in its own head-to-head phase 3 study in previously treated CLL. [(2S,3S)-3-hydroxy-3-methoxycarbonyl-4-methylpentan-2-yl] benzoate manufacturer Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality. [(2S,3S)-3-hydroxy-3-methoxycarbonyl-4-methylpentan-2-yl] benzoate supplier Australia’s ban followed an earlier move by the US Friday to deny entry to foreign nationals who have traveled in China in the last 14 days. [(2S,3S)-3-hydroxy-3-methoxycarbonyl-4-methylpentan-2-yl] benzoate vendor What’s more, also at the EHA meeting, BeiGene’s Brukinsa showed it could outperform Imbruvica at triggering tumor responses while causing fewer cases of atrial fibrillation, a potentially dangerous heart side effect, in its own head-to-head phase 3 study in previously treated CLL. [(2S,3S)-3-hydroxy-3-methoxycarbonyl-4-methylpentan-2-yl] benzoate factory What’s more, also at the EHA meeting, BeiGene’s Brukinsa showed it could outperform Imbruvica at triggering tumor responses while causing fewer cases of atrial fibrillation, a potentially dangerous heart side effect, in its own head-to-head phase 3 study in previously treated CLL.